Incannex Healthcare Inc. - 8-K Filing
Incannex Healthcare Inc. filed to disclose winning the 'Best New Technology Solution for Drug Development' award at the MedTech Breakthrough Awards, recognizing its lead drug candidate IHL-42X in development for obstructive sleep apnea. The Phase 2 RePOSA trial showed statistically significant reductions in AHI and improvements in oxygenation and fatigue. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $IXHL